Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Varun Katta
Institution:
St. Jude Children's Research Hospital
Observed institution:
St. Jude Children's Research Hospital
ORCID:
0000-0002-4565-7335
Observed ORCID:
0000-0002-4565-7335
OpenAlex ID:
A5011919227
CHANGE-seq reveals genetic and epigenetic effects on CRISPR–Cas9 genome-wide activity
2020
·
Cicera R. Lazzarotto
, Nikolay L. Malinin
, et al.
·
Nature Biotechnology
·
318
Genome editing of HBG1 and HBG2 to induce fetal hemoglobin
2019
·
Jean-Yves Métais
, Phillip A. Doerfler
, et al.
·
Blood Advances
·
186
PDF
Human genetic diversity alters off-target outcomes of therapeutic gene editing
2022
·
Samuele Cancellieri
, Jing Zeng
, et al.
·
Nature Genetics
·
131
PDF
Selective haematological cancer eradication with preserved haematopoiesis
2024
·
Simon Garaudé
, Romina Marone
, et al.
·
Nature
·
50
PDF
Sensitive and unbiased genome-wide profiling of base-editor-induced off-target activity using CHANGE-seq-BE
2026
·
Cicera R. Lazzarotto
, Varun Katta
, et al.
·
Nature Biotechnology
·
29
Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells
2025
·
Keerthana Shankar
, Isabelle Zingler-Hoslet
, et al.
·
Molecular Therapy
·
25
Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease
2024
·
Varun Katta
, Kiera O’Keefe
, et al.
·
Molecular Therapy
·
22
PDF
Frequent, context-dependent effects of human genetic variation on Cas9 activity revealed by population-scale GUIDE-seq-2 and deep combinatorial CHANCE-seq profiling
2025
·
Ashley R. Flory
, Cicera R. Lazzarotto
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
17
CHANGE-seq-BE enables simultaneously sensitive and unbiased in vitro profiling of base editor genome-wide activity
2024
·
Cicera R. Lazzarotto
, Varun Katta
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
14
PDF
SAGES1: Clinical Translation of CRISPR Genome Editing Strategy to Induce Fetal Hemoglobin to Treat Sickle Cell Disease
2024
·
Rachel M Levine
, Erin A Dempsey
, et al.
·
Blood
·
6
PDF
Non-genotoxic transplantation and in vivo selection through epitope editing
2026
·
Gabriele Casirati
, Andrea Cosentino
, et al.
·
Nature
·
5
Combined +58 and +55 BCL11A enhancer Editing Yields Exceptional Efficiency, Specificity and HbF Induction in Human and NHP Preclinical Models
2021
·
Jing Zeng
, Selami Demirci
, et al.
·
Blood
·
2
CRISPR-Cas9 Genome Editing of γ-Globin Promoters in Human Hematopoietic Stem Cells to Induce Erythrocyte Fetal Hemoglobin for Treatment of β-Hemoglobinopathies
2019
·
Jean-Yves Metais
, Phillip A Doerfler
, et al.
·
Blood
·
2
Brain-wide Genome Editing via STEP-RNPs for Treatment of Angelman Syndrome
2025
·
Xiaona Lu
, Ying Xie
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
Adenine Base Editing Improves Erythropoiesis in Diamond-Blackfan Anemia Syndrome Patient-Derived Induced Pluripotent Stem Cells
2024
·
Shruthi Suryaprakash
, Lei Han
, et al.
·
Blood
·
1
PDF
Adenine Base Editing Improves Erythropoiesis in Diamond-Blackfan Anemia Syndrome Patient-Derived Induced Pluripotent Stem Cells
2025
·
Shruthi Suryaprakash
, Lei Han
, et al.
·
Transplantation and Cellular Therapy
Human Genetic Diversity Alters Therapeutic Gene Editing Off-Target Outcomes
2021
·
Linda Yingqi Lin
, Samuele Cancellieri
, et al.
·
Blood
Show more works
View as search
Works count:
17
Citation count:
808
H-index:
9
I10-index:
9
Year
Topic
Type